Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Recruitment of CXCR3+ T cells into injured tissues in adult IgA vasculitis patients correlates with disease activity.

Audemard-Verger A, Pillebout E, Jamin A, Berthelot L, Aufray C, Martin B, Sannier A, Daugas E, Déchanet-Merville J, Richard Y, Monteiro R, Lucas B.

J Autoimmun. 2019 Feb 8. pii: S0896-8411(18)30652-8. doi: 10.1016/j.jaut.2019.01.012. [Epub ahead of print]

PMID:
30745186
2.

[Lupus nephritis].

Raimbourg Q, Daugas É.

Nephrol Ther. 2019 Feb 7. pii: S1769-7255(18)30652-7. doi: 10.1016/j.nephro.2018.11.003. [Epub ahead of print] French.

PMID:
30738732
3.

Treatment of cardiac sarcoidosis: A comparative study of steroids and steroids plus immunosuppressive drugs.

Ballul T, Borie R, Crestani B, Daugas E, Descamps V, Dieude P, Dossier A, Extramiana F, van Gysel D, Papo T, Sacre K.

Int J Cardiol. 2019 Feb 1;276:208-211. doi: 10.1016/j.ijcard.2018.11.131. Epub 2018 Nov 30.

PMID:
30527995
4.

Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice.

Chemouny JM, Gleeson PJ, Abbad L, Lauriero G, Boedec E, Le Roux K, Monot C, Bredel M, Bex-Coudrat J, Sannier A, Daugas E, Vrtovsnik F, Gesualdo L, Leclerc M, Berthelot L, Ben Mkaddem S, Lepage P, Monteiro RC.

Nephrol Dial Transplant. 2018 Nov 20. doi: 10.1093/ndt/gfy323. [Epub ahead of print]

PMID:
30462346
5.

An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study).

Rémy P, Audard V, Natella PA, Pelle G, Dussol B, Leray-Moragues H, Vigneau C, Bouachi K, Dantal J, Vrigneaud L, Karras A, Pourcine F, Gatault P, Grimbert P, Ait Sahlia N, Moktefi A, Daugas E, Rigothier C, Bastuji-Garin S, Sahali D; MSN Trial Investigators.

Kidney Int. 2018 Dec;94(6):1217-1226. doi: 10.1016/j.kint.2018.07.021. Epub 2018 Oct 29.

PMID:
30385039
6.

Malakoplakia as a cause of severe hypercalcemia through ectopic 25-hydroxyvitamin D3 1-alpha-hydroxylase expression: A case report.

Chemouny JM, Sannier A, Hanouna G, Champion L, Vrtovsnik F, Daugas E.

Medicine (Baltimore). 2018 Oct;97(40):e12090. doi: 10.1097/MD.0000000000012090.

7.

Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients.

Fouque D, Roth H, Darné B, Bouchet JL, Daugas E, Drüeke TB, Hannedouche T, Jean G, London GM.

Clin Kidney J. 2018 Oct;11(5):710-719. doi: 10.1093/ckj/sfy015. Epub 2018 Mar 15.

8.

Relative prognostic impact of nutrition, anaemia, bone metabolism and cardiovascular comorbidities in elderly haemodialysis patients.

Villain C, Ecochard R, Bouchet JL, Daugas E, Drueke TB, Hannedouche T, Jean G, London G, Roth H, Fouque D.

Nephrol Dial Transplant. 2018 Sep 8. doi: 10.1093/ndt/gfy272. [Epub ahead of print]

PMID:
30202988
9.

IgA kappa light and heavy chain deposition disease in multiple myeloma.

Sannier A, Hanouna G, Daugas E, Vrtovsnik F, Goujon JM, Chemouny JM.

Br J Haematol. 2018 Oct;183(1):13. doi: 10.1111/bjh.15420. Epub 2018 May 29. No abstract available.

PMID:
29808912
10.

Categorical state sequence analysis and regression tree to identify determinants of care trajectory in chronic disease: Example of end-stage renal disease.

Le Meur N, Vigneau C, Lefort M, Lebbah S, Jais JP, Daugas E, Bayat S.

Stat Methods Med Res. 2018 Jan 1:962280218774811. doi: 10.1177/0962280218774811. [Epub ahead of print]

11.

Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.

Terrier B, Pagnoux C, Perrodeau É, Karras A, Khouatra C, Aumaître O, Cohen P, Decaux O, Desmurs-Clavel H, Maurier F, Gobert P, Quémeneur T, Blanchard-Delaunay C, Bonnotte B, Carron PL, Daugas E, Ducret M, Godmer P, Hamidou M, Lidove O, Limal N, Puéchal X, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2018 Aug;77(8):1150-1156. doi: 10.1136/annrheumdis-2017-212768. Epub 2018 May 3.

PMID:
29724729
12.

Disease severity of proliferative lupus nephritis in Maghrebians.

Tamirou F, Costedoat-Chalumeau N, Medkouri G, Daugas E, Hachulla E, Jourde-Chiche N, Karras A, le Guern V, Gnemmi V, Jadoul M, Houssiau FA.

Lupus. 2018 Jul;27(8):1387-1392. doi: 10.1177/0961203318772016. Epub 2018 Apr 27.

PMID:
29703123
13.

Prostaglandin D2 amplifies lupus disease through basophil accumulation in lymphoid organs.

Pellefigues C, Dema B, Lamri Y, Saidoune F, Chavarot N, Lohéac C, Pacreau E, Dussiot M, Bidault C, Marquet F, Jablonski M, Chemouny JM, Jouan F, Dossier A, Chauveheid MP, Gobert D, Papo T, Karasuyama H, Sacré K, Daugas E, Charles N.

Nat Commun. 2018 Feb 20;9(1):725. doi: 10.1038/s41467-018-03129-8.

14.

Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy.

Le Quintrec M, Lapeyraque AL, Lionet A, Sellier-Leclerc AL, Delmas Y, Baudouin V, Daugas E, Decramer S, Tricot L, Cailliez M, Dubot P, Servais A, Mourey-Epron C, Pourcine F, Loirat C, Frémeaux-Bacchi V, Fakhouri F.

Am J Kidney Dis. 2018 Jul;72(1):84-92. doi: 10.1053/j.ajkd.2017.11.019. Epub 2018 Feb 9.

PMID:
29429752
15.

Achievement of Kidney Disease: Improving Global Outcomes mineral and bone targets between 2010 and 2014 in incident dialysis patients in France: the Photo-Graphe3 study.

Fouque D, Roth H, Darné B, Jean-Bouchet L, Daugas E, Drüeke TB, Hannedouche T, Jean G, London GM; French Phosphorus and Calcium Observatory.

Clin Kidney J. 2018 Feb;11(1):73-79. doi: 10.1093/ckj/sfx101. Epub 2017 Sep 23.

16.

Proliferative lupus nephritis in the absence of overt systemic lupus erythematosus: A historical study of 12 adult patients.

Touzot M, Terrier CS, Faguer S, Masson I, François H, Couzi L, Hummel A, Quellard N, Touchard G, Jourde-Chiche N, Goujon JM, Daugas E; Groupe Coopératif sur le Lupus Rénal (GCLR).

Medicine (Baltimore). 2017 Dec;96(48):e9017. doi: 10.1097/MD.0000000000009017.

17.

Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice.

Jamin A, Berthelot L, Couderc A, Chemouny JM, Boedec E, Dehoux L, Abbad L, Dossier C, Daugas E, Monteiro RC, Deschênes G.

J Autoimmun. 2018 May;89:149-161. doi: 10.1016/j.jaut.2017.12.014. Epub 2018 Jan 4.

18.

Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort.

Berthelot L, Jamin A, Viglietti D, Chemouny JM, Ayari H, Pierre M, Housset P, Sauvaget V, Hurtado-Nedelec M, Vrtovsnik F, Daugas E; HSPrognosis Group, Monteiro RC, Pillebout E; members of the HSPrognosis Group .

Nephrol Dial Transplant. 2018 Sep 1;33(9):1579-1590. doi: 10.1093/ndt/gfx300.

PMID:
29126311
19.

[Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].

Jean G, Daugas É, Roth H, Drueke T, Bouchet JL, Hannedouche T, London G, Fouque D.

Nephrol Ther. 2017 Nov;13(6):470-478. doi: 10.1016/j.nephro.2017.02.009. Epub 2017 Aug 23. French.

PMID:
28843391
20.

Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation.

Mkaddem SB, Murua A, Flament H, Titeca-Beauport D, Bounaix C, Danelli L, Launay P, Benhamou M, Blank U, Daugas E, Charles N, Monteiro RC.

Nat Commun. 2017 Aug 15;8(1):246. doi: 10.1038/s41467-017-00294-0.

21.

Basophils contribute to pristane-induced Lupus-like nephritis model.

Dema B, Lamri Y, Pellefigues C, Pacreau E, Saidoune F, Bidault C, Karasuyama H, Sacré K, Daugas E, Charles N.

Sci Rep. 2017 Aug 11;7(1):7969. doi: 10.1038/s41598-017-08516-7.

22.

Serum Iron Protects from Renal Postischemic Injury.

Vaugier C, Amano MT, Chemouny JM, Dussiot M, Berrou C, Matignon M, Ben Mkaddem S, Wang PHM, Fricot A, Maciel TT, Grapton D, Mathieu JRR, Beaumont C, Peraldi MN, Peyssonnaux C, Mesnard L, Daugas E, Vrtovsnik F, Monteiro RC, Hermine O, Ginzburg YZ, Benhamou M, Camara NOS, Flamant M, Moura IC.

J Am Soc Nephrol. 2017 Dec;28(12):3605-3615. doi: 10.1681/ASN.2016080926. Epub 2017 Aug 7.

23.

Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study.

Chavarot N, Verhelst D, Pardon A, Caudwell V, Mercadal L, Sacchi A, Leonardi C, Le Guern V, Karras A, Daugas E; Groupe Coopératif sur le Lupus Rénal.

Medicine (Baltimore). 2017 Jul;96(27):e7429. doi: 10.1097/MD.0000000000007429.

24.

International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.

Kleinmann JF, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacre K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, Cacoub P, Caillard S, Chiche L, Chosidow O, Costedoat-Chalumeau N, Daien C, Daugas E, Derdèche N, Doria A, Fain O, Fakhouri F, Farge D, Gabay C, Guillo S, Hachulla E, Hajjaj-Hassouni N, Hamidou M, Houssiau FA, Jourde-Chiche N, Koné-Paut I, Ladjouz-Rezig A, Lambotte O, Lipsker D, Mariette X, Martin-Silva N, Martin T, Maurier F, Meckenstock R, Mékinian A, Meyer O, Mohamed S, Morel J, Moulin B, Mulleman D, Papo T, Poindron V, Puéchal X, Punzi L, Quartier P, Sailler L, Smail A, Soubrier M, Sparsa A, Tazi-Mezalek Z, Zakraoui L, Zuily S, Sibilia J, Gottenberg JE.

Autoimmun Rev. 2017 Jun;16(6):650-657. doi: 10.1016/j.autrev.2017.04.011. Epub 2017 Apr 18.

PMID:
28434948
25.

Early Phase Mast Cell Activation Determines the Chronic Outcome of Renal Ischemia-Reperfusion Injury.

Danelli L, Madjene LC, Madera-Salcedo I, Gautier G, Pacreau E, Ben Mkaddem S, Charles N, Daugas E, Launay P, Blank U.

J Immunol. 2017 Mar 15;198(6):2374-2382. doi: 10.4049/jimmunol.1601282. Epub 2017 Feb 6.

26.

Renal biopsies should be performed whenever treatment strategies depend on renal involvement.

Divard G, Sannier A, Hanouna G, Daugas E, Vrtovsnik F, Chemouny JM.

Ann Rheum Dis. 2017 Aug;76(8):e27. doi: 10.1136/annrheumdis-2016-210933. Epub 2017 Jan 25. No abstract available.

PMID:
28122762
27.

Facilitating access to the renal transplant waiting list does not increase the number of transplantations: comparative study of two French regions.

Lefort M, Vigneau C, Laurent A, Lebbah S, Le Meur N, Jais JP, Daugas E, Bayat S.

Clin Kidney J. 2016 Dec;9(6):849-857. Epub 2016 Sep 9.

28.

Metastatic Renal Cell Carcinoma in a Renal Allograft: A Sustained Complete Remission After Stimulated Rejection.

Champion L, Culine S, Desgranchamps F, Benali K, Verine J, Daugas E.

Am J Transplant. 2017 Apr;17(4):1125-1128. doi: 10.1111/ajt.14151. Epub 2017 Jan 13.

29.

Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis.

Jarrot PA, Chiche L, Hervier B, Daniel L, Vuiblet V, Bardin N, Bertin D, Terrier B, Amoura Z, Andrés E, Rondeau E, Hamidou M, Pennaforte JL, Halfon P, Daugas E, Dussol B, Puéchal X, Kaplanski G, Jourde-Chiche N.

Medicine (Baltimore). 2016 May;95(22):e3748. doi: 10.1097/MD.0000000000003748.

30.

Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life.

Pugnet G, Pagnoux C, Terrier B, Perrodeau E, Puéchal X, Karras A, Khouatra C, Aumaître O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quemeneur T, Blanchard-Delaunay C, Godmer P, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group.

Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S54-9. Epub 2016 Mar 25.

PMID:
27049404
31.

Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide.

Audemard-Verger A, Martin Silva N, Verstuyft C, Costedoat-Chalumeau N, Hummel A, Le Guern V, Sacré K, Meyer O, Daugas E, Goujard C, Sultan A, Lobbedez T, Galicier L, Pourrat J, Le Hello C, Godin M, Morello R, Lambert M, Hachulla E, Vanhille P, Queffeulou G, Potier J, Dion JJ, Bataille P, Chauveau D, Moulis G, Farge-Bancel D, Duhaut P, Saint-Marcoux B, Deroux A, Manuzak J, Francès C, Aumaitre O, Bezanahary H, Becquemont L, Bienvenu B.

PLoS One. 2016 Mar 22;11(3):e0151696. doi: 10.1371/journal.pone.0151696. eCollection 2016.

32.

[Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion].

Mathian A, Arnaud L, Adoue D, Agard C, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L, Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O, Miyara M, Morell-Dubois S, Ninet J, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Sibilia J, Viallard JF, Viau Brabant A, Hanslik T, Amoura Z; le groupe France lupus érythémateux systémique réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides.

Rev Med Interne. 2016 May;37(5):307-20. doi: 10.1016/j.revmed.2016.01.005. Epub 2016 Feb 16. French.

PMID:
26899776
33.

Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients.

Merle E, Roth H, London GM, Jean G, Hannedouche T, Bouchet JL, Drüeke T, Fouque D, Daugas E; French Calcium and Phosphate Observatory.

Kidney Int. 2016 Mar;89(3):666-74. doi: 10.1016/j.kint.2015.12.001. Epub 2016 Feb 2.

34.

Protective role of mouse IgG1 in cryoglobulinaemia; insights from an animal model and relevance to human pathology.

Chemouny JM, Hurtado-Nedelec M, Flament H, Ben Mkaddem S, Daugas E, Vrtovsnik F, Berthelot L, Monteiro RC.

Nephrol Dial Transplant. 2016 Aug;31(8):1235-42. doi: 10.1093/ndt/gfv335. Epub 2015 Sep 26. Review.

PMID:
26410885
35.

Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease: A Retrospective Study of 10 Cases.

Dauvergne M, Moktefi A, Rabant M, Vigneau C, Kofman T, Burtey S, Corpechot C, Stehlé T, Desvaux D, Rioux-Leclercq N, Rouvier P, Knebelmann B, Boffa JJ, Frouget T, Daugas E, Jablonski M, Dahan K, Brocheriou I, Remy P, Grimbert P, Lang P, Chazouilleres O, Sahali D, Audard V.

Medicine (Baltimore). 2015 Jul;94(30):e1243. doi: 10.1097/MD.0000000000001243.

36.

Outcome of patients with systemic lupus erythematosus on chronic dialysis: an observational study of incident patients of the French National Registry 2002-2012.

Levy B, Couchoud C, Rougier JP, Jourde-Chiche N, Daugas E.

Lupus. 2015 Sep;24(10):1111-21. doi: 10.1177/0961203315578763. Epub 2015 Mar 25.

PMID:
25813872
37.

Brief Report: Childhood-Onset Systemic Necrotizing Vasculitides: Long-Term Data From the French Vasculitis Study Group Registry.

Iudici M, Puéchal X, Pagnoux C, Quartier P, Agard C, Aouba A, Büchler M, Cevallos R, Cohen P, de Moreuil C, Guilpain P, Le Quellec A, Roblot P, Serratrice J, Bachmeyer C, Daugas É, Terrier B, Mouthon L, Guillevin L; French Vasculitis Study Group.

Arthritis Rheumatol. 2015 Jul;67(7):1959-65. doi: 10.1002/art.39122.

38.

Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.

Papista C, Lechner S, Ben Mkaddem S, LeStang MB, Abbad L, Bex-Coudrat J, Pillebout E, Chemouny JM, Jablonski M, Flamant M, Daugas E, Vrtovsnik F, Yiangou M, Berthelot L, Monteiro RC.

Kidney Int. 2015 Aug;88(2):276-85. doi: 10.1038/ki.2015.94. Epub 2015 Mar 25.

PMID:
25807036
39.

[Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion].

Arnaud L, Mathian A, Adoue D, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L, Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O, Miyara M, Morell-Dubois S, Ninet J, Papo T, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Schmidt J, Sibilia J, Viallard JF, Viau Brabant A, Wahl D, Bruckert E, Amoura Z; groupe France Lupus Érythémateux systémique Réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides.

Rev Med Interne. 2015 Jun;36(6):372-80. doi: 10.1016/j.revmed.2014.10.009. Epub 2014 Nov 14. French.

PMID:
25455954
40.

Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.

Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaître O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quémeneur T, Blanchard-Delaunay C, Godmer P, Puéchal X, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L; French Vasculitis Study Group.

N Engl J Med. 2014 Nov 6;371(19):1771-80. doi: 10.1056/NEJMoa1404231.

41.

Immunoglobulin E plays an immunoregulatory role in lupus.

Dema B, Charles N, Pellefigues C, Ricks TK, Suzuki R, Jiang C, Scheffel J, Hasni S, Hoffman V, Jablonski M, Sacré K, Gobert D, Papo T, Daugas E, Crampton S, Bolland S, Rivera J.

J Exp Med. 2014 Oct 20;211(11):2159-68. doi: 10.1084/jem.20140066. Epub 2014 Sep 29.

42.

Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.

Guitard J, Hebral AL, Fakhouri F, Joly D, Daugas E, Rivalan J, Guigonis V, Ducret F, Presne C, Pirson Y, Hourmant M, Glachant JC, Vendrely B, Moranne O, Faguer S, Chauveau D.

Nephrol Dial Transplant. 2014 Nov;29(11):2084-91. doi: 10.1093/ndt/gfu209. Epub 2014 Jun 11.

PMID:
24920841
43.

Mast cells in renal inflammation and fibrosis: lessons learnt from animal studies.

Madjene LC, Pons M, Danelli L, Claver J, Ali L, Madera-Salcedo IK, Kassas A, Pellefigues C, Marquet F, Dadah A, Attout T, El-Ghoneimi A, Gautier G, Benhamou M, Charles N, Daugas E, Launay P, Blank U.

Mol Immunol. 2015 Jan;63(1):86-93. doi: 10.1016/j.molimm.2014.03.002. Epub 2014 May 3. Review.

PMID:
24793464
44.

[Proliferative lupus nephritis treatment: practice survey in nephrology and internal medicine in France].

Jourde-Chiche N, Chiche L, Mancini J, Daniel L, Bardin N, Burtey S, Gondouin B, Dussol B, Harlé JR, Hamidou M, Meulders Q, Daugas E; Groupe Coopératif sur le Lupus Rénal.

Nephrol Ther. 2014 Jun;10(3):170-6. doi: 10.1016/j.nephro.2013.11.006. Epub 2014 Apr 3. French.

PMID:
24703567
45.

The risk of systemic lupus erythematosus associated with vaccines: an international case-control study.

Grimaldi-Bensouda L, Le Guern V, Kone-Paut I, Aubrun E, Fain O, Ruel M, Machet L, Viallard JF, Magy-Bertrand N, Daugas E, Rossignol M, Abenhaim L, Costedoat-Chalumeau N; PGRx Lupus Study Group.

Arthritis Rheumatol. 2014 Jun;66(6):1559-67. doi: 10.1002/art.38429.

46.

Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis.

Dema B, Pellefigues C, Hasni S, Gault N, Jiang C, Ricks TK, Bonelli MM, Scheffel J, Sacré K, Jablonski M, Gobert D, Papo T, Daugas E, Illei G, Charles N, Rivera J.

PLoS One. 2014 Feb 28;9(2):e90424. doi: 10.1371/journal.pone.0090424. eCollection 2014.

47.

Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction.

Beghdadi W, Madjene LC, Claver J, Pejler G, Beaudoin L, Lehuen A, Daugas E, Blank U.

Kidney Int. 2013 Aug;84(2):317-26. doi: 10.1038/ki.2013.98. Epub 2013 Mar 20.

48.

Acute renal infarction: a case series.

Bourgault M, Grimbert P, Verret C, Pourrat J, Herody M, Halimi JM, Karras A, Amoura Z, Jourde-Chiche N, Izzedine H, François H, Boffa JJ, Hummel A, Bernadet-Monrozies P, Fouque D, Canouï-Poitrine F, Lang P, Daugas E, Audard V.

Clin J Am Soc Nephrol. 2013 Mar;8(3):392-8. doi: 10.2215/CJN.05570612. Epub 2012 Nov 30.

49.

Is renal allograft dysfunction a risk factor for severe infection in kidney transplant recipients?

Mourad G, Dussol B, Daugas E, Joly D, Juillard L, Henri P, Stroumza P, Touam M; ANTICIPE Study Scientific Board.

Transplant Proc. 2012 Nov;44(9):2821-3. doi: 10.1016/j.transproceed.2012.09.088.

PMID:
23146532
50.

[Prepare: cross-sectional study on management of chronic kidney disease by nephrologists before dialysis in France].

Daugas E, Dussol B, Henri P, Joly D, Juillard L, Michaut P, Mourad G, Stroumza P, Touam M.

Nephrol Ther. 2012 Nov;8(6):439-50. doi: 10.1016/j.nephro.2012.06.003. Epub 2012 Sep 28. French.

PMID:
23022292

Supplemental Content

Loading ...
Support Center